Commitment to delivering innovative medical technologies creates most
versatile cordless ultrasonic offering in the industry
DUBLIN, Ireland--(BUSINESS WIRE)--Sep. 18, 2014--
plc (NYSE:COV) today announced the expansion of its
Sonicision™ Cordless Ultrasonic Dissection Device portfolio, following
U.S. Food and Drug Administration 510(k) clearance of three additional
device lengths: 13 cm, 26 cm, and 48 cm. With the most versatile
cordless ultrasonic portfolio in the industry, Covidien now offers
surgeons more options when performing pediatric, urological and
bariatric procedures on patients of all sizes.
The U.S. Food and Drug Administration cleared three new device shaft lengths in addition to the current 39 cm device. Covidien’s Sonicision™ Cordless Ultrasonic Dissection Device portfolio consists of: 13 cm, 26 cm, 39 cm and 48 cm. (Photo: Business Wire)
“Covidien is a pioneer in developing energy-based medical devices and
the Sonicision system’s groundbreaking cordless technology continues to
transform how minimally invasive surgery is performed,” said Chris
Barry, president, Advanced Surgical, Covidien. “These new device lengths
enable surgeons to use Sonicision technology in a more diverse range of
surgical procedures while avoiding the need for cords and separate
As the only cordless ultrasonic dissection device currently on the
market, the Sonicision system gives surgeons complete freedom of
movement in the operating room. Increased mobility eliminates the
frustration of managing cords in a sterile field and helps to increase
procedural efficiencies. In addition, reducing the number of cords in
the operating room (OR) contributes to a safer OR and patient experience1.
The Sonicision system is used in a wide variety of general, bariatric,
colorectal, gynecological and urological surgical procedures. The
device’s streamlined design allows a surgeon’s eyes to remain in the
surgical field rather than on the instrument. The new device lengths
allow surgeons to expand their use of the Sonicision system to an
increasing number of procedures, including pediatric colectomy,
splenectomy, and appendectomy.
The full cordless ultrasonic portfolio is currently available in the
United States. For more information on Sonicision products, visit: covidien.com/sonicision.
Covidien is a global health care leader that understands the challenges
faced by providers and their patients and works to address them with
innovative medical technology solutions and patient care products.
Inspired by patients and caregivers, Covidien’s team of dedicated
professionals is privileged to help save and improve lives around the
world. With more than 38,000 employees, Covidien operates in 150-plus
countries and had 2013 revenue of $10.2 billion. To learn more about our
business visit www.covidien.com
or connect with us on Twitter.
1 Reduction of cords improves safety in the O.R. AORN Report:
Brogmus G, Leone W, Butler L. Hernandez E . Best practices in OR
suite layout and equipment choices to reduce slips, trips and falls.
AORN (Association of PerOperative Registered Nurses) J86:384-398
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140918005167/en/
Source: Covidien plc
John Jordan, 508-452-4891
Vice President, Communications
Lannum, CFA, 508-452-4343
Vice President, Investor Relations
Sr. Director, Investor Relations